Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia

Published:2012-07 Issue:7 Volume:36 Page:862-867
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Vázquez-Franco José E.,Reyes-Maldonado Elba,Vela-Ojeda Jorge,Domínguez-López Maria L.,Lezama Ruth A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference45 articles.

1. The hallmarks of cancer;Hanahan;Cell,2000

2. FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis;Jagani;Biochim Biophys Acta,2008

3. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

4. Focus on myeloproliferative diseases and myelodysplastic syndromes;Van Etten;Cancer Cell,2004

5. Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice;Hu;Proc Natl Acad Sci USA,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central gene transcriptional regulatory networks shaping monocyte development in bone marrow;Frontiers in Immunology;2022-10-11

2. M1‑like tumor‑associated macrophages enhance proliferation and anti‑apoptotic ability of liver cancer cells via activating the NF‑κB signaling pathway;Molecular Medicine Reports;2022-09-06

3. Hemopoietic Cell Kinase amplification with Protein Tyrosine Phosphatase Receptor T depletion leads to polycythemia, aberrant marrow erythoid maturation, and splenomegaly;Scientific Reports;2019-05-07

4. Cell proliferation and inhibition of apoptosis are related to c-Kit activation in leukaemic lymphoblasts;Hematology;2018-03-01

5. A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models;Oncotarget;2017-12-01